Literature DB >> 20360457

Two haplotypes of the P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion.

Leanne Stokes1, Stephen J Fuller, Ronald Sluyter, Kristen K Skarratt, Ben J Gu, James S Wiley.   

Abstract

The P2X(7) receptor is an ATP-gated cation channel expressed in immune cells and plays a role in proinflammatory cytokine release from monocytes and macrophages. This study investigated the coinheritance of 12 functionally relevant single nucleotide polymorphisms (SNPs) in the human P2X(7) gene (P2RX7), and the functional effect of each singly and in combination was assessed by measurements of ATP-induced currents and ethidium(+) uptake. Genotyping of 3430 Caucasian subjects identified 4 common haplotypes in addition to the common (wild-type) P2X(7)-1. Two haplotypes (denoted P2X(7)-2 and P2X(7)-4) contained various combinations of gain-of-function SNPs. P2X(7)-4 was identified uniquely by the Gln-460 to Arg polymorphism (rs2230912). When expressed in HEK-293 cells, recombinant P2X(7)-2, and P2X(7)-4 haplotypes displayed a 3-fold and 5-fold increase, respectively, in receptor function compared to the wild-type P2X(7)-1. Both P2X(7) haplotypes contained the Ala-348>Thr polymorphism (rs1718119), and this mutation was critical for the gain-of-function effect. Peripheral blood monocytes and erythrocytes from subjects homozygous for gain-of-function P2X(7) haplotypes exhibited increased ATP-induced ethidium(+) uptake and (86)Rb(+) efflux, respectively, and this correlated with increased IL-1beta secretion from LPS-primed monocytes. Inheritance of these P2X(7) haplotypes predisposing to increased proinflammatory cytokine secretion may be important in genetic association studies of inflammatory, infectious, and psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360457     DOI: 10.1096/fj.09-150862

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  64 in total

1.  P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells.

Authors:  Safina Gadeock; Aleta Pupovac; Vanessa Sluyter; Mari Spildrejorde; Ronald Sluyter
Journal:  Purinergic Signal       Date:  2012-06-05       Impact factor: 3.765

2.  Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures.

Authors:  Niklas R Jørgensen; Lise B Husted; Kristen K Skarratt; Leanne Stokes; Charlotte L Tofteng; Torben Kvist; Jens-Erik B Jensen; Pia Eiken; Kim Brixen; Stephen Fuller; Rory Clifton-Bligh; Alison Gartland; Peter Schwarz; Bente L Langdahl; James S Wiley
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

Review 3.  Integrating neuroimmune systems in the neurobiology of depression.

Authors:  Eric S Wohleb; Tina Franklin; Masaaki Iwata; Ronald S Duman
Journal:  Nat Rev Neurosci       Date:  2016-06-09       Impact factor: 34.870

4.  Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.

Authors:  Robert E Sorge; Tuan Trang; Ruslan Dorfman; Shad B Smith; Simon Beggs; Jennifer Ritchie; Jean-Sebastien Austin; Dmitri V Zaykin; Heather Vander Meulen; Michael Costigan; Teri A Herbert; Merav Yarkoni-Abitbul; David Tichauer; Jessica Livneh; Edith Gershon; Ming Zheng; Keith Tan; Sally L John; Gary D Slade; Joanne Jordan; Clifford J Woolf; Gary Peltz; William Maixner; Luda Diatchenko; Ze'ev Seltzer; Michael W Salter; Jeffrey S Mogil
Journal:  Nat Med       Date:  2012-03-25       Impact factor: 53.440

5.  Cholesterol, Inflammasomes, and Atherogenesis.

Authors:  Jose M Ordovas-Montanes; Jose M Ordovas
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-02-01

6.  Residues 155 and 348 contribute to the determination of P2X7 receptor function via distinct mechanisms revealed by single-nucleotide polymorphisms.

Authors:  Helen J Bradley; Jocelyn M Baldwin; G Ranjan Goli; Brian Johnson; Jie Zou; Asipu Sivaprasadarao; Stephen A Baldwin; Lin-Hua Jiang
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

7.  Functional polymorphisms in the P2X7 receptor gene are associated with osteoporosis.

Authors:  L B Husted; T Harsløf; L Stenkjær; M Carstens; N R Jørgensen; B L Langdahl
Journal:  Osteoporos Int       Date:  2012-06-16       Impact factor: 4.507

8.  P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy.

Authors:  Loren C Denlinger; David M Manthei; Max A Seibold; Kwangmi Ahn; Eugene Bleecker; Homer A Boushey; William J Calhoun; Mario Castro; Vernon M Chinchili; John V Fahy; Greg A Hawkins; Nicolina Icitovic; Elliot Israel; Nizar N Jarjour; Tonya King; Monica Kraft; Stephen C Lazarus; Erik Lehman; Richard J Martin; Deborah A Meyers; Stephen P Peters; Dagna Sheerar; Lei Shi; E Rand Sutherland; Stanley J Szefler; Michael E Wechsler; Christine A Sorkness; Robert F Lemanske
Journal:  Am J Respir Crit Care Med       Date:  2012-11-09       Impact factor: 21.405

9.  Mitochondrial superoxide generation enhances P2X7R-mediated loss of cell surface CD62L on naive human CD4+ T lymphocytes.

Authors:  John G Foster; Edward Carter; Iain Kilty; Amanda B MacKenzie; Stephen G Ward
Journal:  J Immunol       Date:  2013-01-14       Impact factor: 5.422

10.  Pharmacological and genetic characterisation of the canine P2X4 receptor.

Authors:  Reece A Sophocleous; Tracey Berg; Rocio K Finol-Urdaneta; Vanessa Sluyter; Shikara Keshiya; Lachlan Bell; Stephen J Curtis; Belinda L Curtis; Aine Seavers; Rachael Bartlett; Mark Dowton; Leanne Stokes; Lezanne Ooi; Ronald Sluyter
Journal:  Br J Pharmacol       Date:  2020-03-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.